About Hummingbird Bioscience
Opportunity to work at the cutting edge of drug development
Hummingbird Bioscience is an innovative biotechnology company with operations at JLABS in Texas and South San Francisco and in Singapore, focused on leveraging the rapid advances in systems biology to enhance therapeutics discovery and development. We have developed proprietary technologies that significantly improve therapeutic antibody discovery and development and possess a pipeline of promising oncology / immuno-oncology assets slated to enter Phase I trials in 2020. We are well-funded by global venture capital.